Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2014 16:00 ET | Source: 21st North Inc.

Urologix Reports First Quarter Fiscal Year 2015 Results

Recent Quarter Highlights Reduced operating expenses 44% compared to the first quarter of the prior year. Net loss reduced by 67% to $437,000 from a net loss of $1,334,000 in the first...
August 19, 2014 16:00 ET | Source: 21st North Inc.

Urologix Reports Fourth Quarter and Fiscal Year 2014 Results

Recent Highlights Urologix restructured the company in April 2014 which reduced cash utilization in the fourth quarter to $98,000 Cost-effectiveness data covering Cooled ThermoTherapyTM...
May 06, 2014 16:05 ET | Source: 21st North Inc.

Urologix Announces Poster Presentation at the 2014 Annual Meeting of the American Urological Association

The poster "Cost-Effectiveness Markov Model Comparing High- and Low-Energy Transurethral Microwave Therapy for Benign Prostatic Hyperplasia" will be presented Tuesday morning, May 20th, by Dr....
May 06, 2014 16:00 ET | Source: 21st North Inc.

Urologix Reports Fiscal Year 2014 Third Quarter Results

Third quarter revenue totaled $3.4 million Cash balance of $816,000 as of March 31, 2014 Annualized expenses reduced by over $4.0 million since January 1, 2014 MINNEAPOLIS, May 6, 2014...
April 10, 2014 17:00 ET | Source: 21st North Inc.

Urologix Announces Strategic Restructuring, Reports Preliminary Revenue and Cash Results for the Third Quarter of Fiscal Year 2014

Third quarter revenue totaled $3.4 million Cash balance of $816 thousand as of March 31, 2014 MINNEAPOLIS, April 10, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc....
February 04, 2014 16:05 ET | Source: 21st North Inc.

Urologix Secures Extension of Credit Facility

MINNEAPOLIS, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced that...
February 04, 2014 16:00 ET | Source: 21st North Inc.

Urologix Reports Fiscal Year 2014 Second Quarter Results

MINNEAPOLIS, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today reported...
January 08, 2014 16:00 ET | Source: 21st North Inc.

Urologix Announces Strategic Restructuring, Reports Preliminary Revenue and Cash Results for the Second Quarter of Fiscal Year 2014

Second quarter revenue totaled $3.8 million, up 1% sequentially Cash balance of $1.3M as of December 31, 2013 MINNEAPOLIS, Jan. 8, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc....
October 29, 2013 16:00 ET | Source: 21st North Inc.

Urologix Reports Fiscal Year 2014 First Quarter Results

Executive Summary First quarter revenue totaled $3.8 million, down 4.8% year-over-year. Reaffirms fiscal year 2014 total revenue guidance in the range of $15 million to $17...
August 20, 2013 16:00 ET | Source: 21st North Inc.

Urologix Reports Fourth Quarter and Fiscal Year 2013 Results

Executive Summary Fiscal year 2013 revenue totaled $16.6 million in-line with the Company's fiscal year guidance range of $16.0 million to $17.0 million. Fourth quarter revenue totaled...